| Date | Time | Source | Headline | Symbol | Company |
| 02/01/2012 | 11:18AM | Zacks | New Study for Alkermes' Vivitrol - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/31/2012 | 8:43AM | Dow Jones News | UPDATE: Lilly 4Q Net Drops 27% As Zyprexa Sales Drop 44% | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/31/2012 | 8:38AM | Zacks | Zyprexa Pulls Down Lilly's 4Q Sales - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/31/2012 | 4:00AM | Zacks | Company News for January 31, 2012 - Corporate Summary | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/30/2012 | 5:42PM | Dow Jones News | US Stocks Edge Lower As Europe's Debt Flashpoints Weigh | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/30/2012 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast 2011 Year-End Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/30/2012 | 9:01AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/30/2012 | 8:45AM | Zacks | Third Time Lucky for Amylin's Bydureon - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/30/2012 | 8:02AM | Dow Jones News | US Stock Futures Lower On Renewed Worries Over Greece | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/27/2012 | 5:56PM | Dow Jones News | 2nd UPDATE: FDA Approves Amylin's Bydureon Diabetes Drug After Delays | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/27/2012 | 4:46PM | Dow Jones News | UPDATE: FDA Approves Amylin's Bydureon Diabetes Drug After Delays | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/27/2012 | 4:12PM | Dow Jones News | FDA Approves Amylin's Bydureon Diabetes Drug After Delays | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/27/2012 | 3:39PM | PR Newswire (US) | FDA Approves BYDUREON™ -- The First and Only Once-Weekly Treatment for Type 2 Diabetes | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/19/2012 | 4:46PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/19/2012 | 4:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/12/2012 | 7:31PM | Dow Jones News | UK Body Recommends Lilly, Amylin Diabetes Drug Bydureon | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/12/2012 | 4:37PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/12/2012 | 4:37PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/12/2012 | 4:36PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/12/2012 | 4:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/12/2012 | 4:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/10/2012 | 8:36AM | Zacks | Amylin Provides Strategy Update - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/09/2012 | 5:05PM | PR Newswire (US) | Amylin Outlines Corporate Strategy to Maximize Global Value of Diabetes Franchise and Advance Key Pipeline Candidates | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/03/2012 | 8:00AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/07/2011 | 4:07PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/23/2011 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/15/2011 | 4:10AM | Zacks | Company News for November 15, 2011 - Corporate Summary | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/11/2011 | 9:00AM | Marketwired | Europe Situation Forecasts Change -- Report Highlights Amylin Pharmaceuticals, Inc. and priceline.com Incorporated | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/09/2011 | 8:00AM | PR Newswire (US) | Amylin Pharmaceuticals Announces Date and Time Change to Previously Announced Presentation at the Credit Suisse 2011 Healthca... | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/09/2011 | 7:28AM | Zacks | Amylin, Lilly Part Ways - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |